microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1

References

• de Castro Sant’ Anna C, Junior AGF, Soares P, et al. Molecular biology as a tool for the treatment of cancer. Clin Exp Med. 2018 Nov;18(4): 457–464.
   PubMed Web of Science ®Google Scholar
• Williams MJ, Sottoriva A, Graham TA. Measuring clonal evolution in cancer with genomics. Annu Rev Genomics Hum Genet. 2019 Aug 31;20(1): 309–329.
   PubMedGoogle Scholar
• Arneth B. Tumor Microenvironment. Medicina (Kaunas). 2019 Dec 30;56(1): 15.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Lei KF, Han F. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12): 3855–3864.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li L. Photodynamic combinational therapy in cancer treatment. J BUON. 2018 May-Jun;23(3): 561–567.
   PubMed Web of Science ®Google Scholar
• Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018 Sep 5;834: 188–196.
   PubMed Web of Science ®Google Scholar
• Baskar R, Ka L, Yeo R, et al. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3): 193–199.
   PubMed Web of Science ®Google Scholar
• Cao W, Chen Y, Han W, et al. Potentiality of α-fetoprotein (AFP) and soluble intercellular adhesion molecule-1 (sICAM-1) in prognosis prediction and immunotherapy response for patients with hepatocellular carcinoma [published online ahead of print, 2021 Oct 26]. Bioengineered. 2021; 10.1080/21655979.2021.1990195.
   Web of Science ®Google Scholar
• Lei Y, Tang R, Xu J, et al. Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features. Bioengineered. 2021;12(1): 3593–3602.
   PubMed Web of Science ®Google Scholar
• Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70(2): 86–104.
   PubMed Web of Science ®Google Scholar
• Tu X, Qin B, Zhang Y, et al. PD-L1 (B7-H1) competes with the RNA exosome to regulate the DNA damage response and can be targeted to sensitize to radiation or Chemotherapy. Mol Cell. 2019 Jun 20;74(6): 1215–1226.e4.
   PubMed Web of Science ®Google Scholar
• Kwok G, Yau TC, Chiu JW, et al. Pembrolizumab (Keytruda). Hum Vaccin Immunother. 2016 Nov;12(11): 2777–2789.
   PubMed Web of Science ®Google Scholar
• Robert C, Schachter J, Long GV, et al. KEYNOTE-006 investigators. pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015 Jun 25;372(26): 2521–2532.
   PubMed Web of Science ®Google Scholar
• Gálffy G, Puskás R. A pembrolizumab szerepe a nem kissejtes tüdõrák (NSCLC) kezelésében [Role of pembrolizumab in the treatment of non-small cell lung cancer (NSCLC)]. Magy Onkol. 2017 Mar 8;61(1): 107–110.
   PubMedGoogle Scholar
• Muller M, Schouten RD, De Gooijer CJ, et al. Pembrolizumab for the treatment of non-small cell lung cancer. Expert Rev Anticancer Ther. 2017 May;17(5): 399–409.
   PubMed Web of Science ®Google Scholar
• Ilson DH. Advances in the treatment of gastric cancer. Curr Opin Gastroenterol. 2018 Nov;34(6): 465–468.
   PubMed Web of Science ®Google Scholar
• Manvati MKS, Khan J, Verma N, et al. Association of miR-760 with cancer: an overview. Gene. 2020 Jul 15;747: 144648.
   PubMed Web of Science ®Google Scholar
• Caiazza C, Mallardo M. The Roles of miR-25 and its targeted genes in development of human cancer. Microrna. 2016;5(2): 113–119.
   PubMedGoogle Scholar
• Liang Z, Xu J, Ma Z, et al. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9. Bioengineered. 2020;11(1): 70–80.
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020;11(1): 972–983.
   PubMed Web of Science ®Google Scholar
• Feng Q, Wu X, Li F, et al. miR-27b inhibits gastric cancer metastasis by targeting NR2F2. Protein Cell. 2017 Feb;8(2): 114–122.
   PubMed Web of Science ®Google Scholar
• Hong BS, Ryu HS, Kim N, et al. Tumor Suppressor miRNA-204-5p Regulates growth, metastasis, and immune microenvironment remodeling in breast cancer. Cancer Res. 2019;79(7): 1520–1534.
   PubMed Web of Science ®Google Scholar
• Iqbal MA, Arora S, Prakasam G, et al. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2019;70: 3–20.
   PubMed Web of Science ®Google Scholar
• Bonomi M, Ahmed T, Addo S, et al. Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: an interim analysis. Oncol Lett. 2019;17(1): 1349–1356.
   PubMed Web of Science ®Google Scholar
• Zhao F, Pu Y, Cui M, et al. MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene. Cancer Cell Int. 2017 Nov2;17(1): 100.
   PubMedGoogle Scholar
• Chen Y, Wang X, Cheng J, et al. MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells. Oncol Rep. 2016 Dec;36(6): 3379–3386.
   PubMed Web of Science ®Google Scholar
• Yang H, Lin J, Jiang J, et al. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Cell Cycle. 2020;19(21): 2939–2954.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li TE, Chen M, et al. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway. Aging (Albany NY). 2020 Jan 27;12(2): 1867–1887. Epub 2020 Jan 27. PMID: 31986487; PMCID: PMC7053600.
   PubMedGoogle Scholar
• Wei T, Cheng S, Fu XN, et al. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164. Biosci Rep. 2020 Jul 31;40(7): BSR20192795. PMID: 32364222; PMCID: PMC7378263.
   PubMedGoogle Scholar
• Liu X, Wang H, Tao GL, et al. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1. Eur Rev Med Pharmacol Sci. 2020 Nov;24(21): 11006–11015. PMID: 33215415.
   PubMed Web of Science ®Google Scholar
• Jin P, Liu Y, Wang R. STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance. Biosci Rep. 2018 Aug 29;38(4): BSR20180547. PMID: 30061175; PMCID: PMC6131203.
   PubMedGoogle Scholar
• Chen J, Yu Y, Li H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 2019 Mar 2;18(1): 33. PMID: 30825877; PMCID: PMC6397746.
   PubMed Web of Science ®Google Scholar
• Liu H, Deng H, Zhao Y, et al. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res. 2018 Nov21;37(1): 279. PMID: 30463570; PMCID: PMC6249781.
   PubMedGoogle Scholar
• Lou Q, Liu R, Yang X, et al. miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer. J Immunother Cancer. 2019 Aug 7;7(1): 210. PMID: 31391111; PMCID: PMC6686234.
   PubMed Web of Science ®Google Scholar
• Baskar R, Itahana K. Radiation therapy and cancer control in developing countries: can we save more lives? Int J Med Sci. 2017 Jan 1;14(1): 13–17.
   PubMed Web of Science ®Google Scholar
• Sampath S. Treatment: radiation Therapy. Cancer Treat Res. 2016;170: 105–118.
   PubMedGoogle Scholar
• Wu SX, Wang LH. [Current status and perspectives of radiotherapy for esophageal cancer]. Zhonghua Zhong Liu Za Zhi.2016 Sep 23;38(9): 650–654. Chinese.
   PubMedGoogle Scholar
• Abshire D, Lang MK. The evolution of radiation therapy in treating cancer. Semin Oncol Nurs. 2018 May;34(2): 151–157.
   PubMed Web of Science ®Google Scholar
• Peng L, Li S, Li Y, et al. Regulation of BTG3 by microRNA-20b-5p in non-small cell lung cancer. Oncol Lett. 2019;18(1): 137–144.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen D, Jin L, et al. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis. Mol Med Rep. 2016;13(2): 1895–1901.
   PubMed Web of Science ®Google Scholar
• Ulivi P, Canale M, Passardi A, et al. Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as predictors of bevacizumab efficacy in patients with metastatic colorectal cancer. Int J Mol Sci. 2018;19(1): 307.
   PubMed Web of Science ®Google Scholar
• Tang D, Yang Z, Long F, et al. Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer. Cell Signal. 2019;57: 21–28.
   PubMed Web of Science ®Google Scholar
• Han J, Hu J, Sun F, et al. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway. Mol Cell Biochem. 2020;476(2): 689-698.
   Web of Science ®Google Scholar
• Yu Z, Wang Y, Deng J, et al. Long non-coding RNA COL4A2-AS1 facilitates cell proliferation and glycolysis of colorectal cancer cells via miR-20b-5p/hypoxia inducible factor 1 alpha subunit axis. Bioengineered. 2021 Dec;12(1): 6251–6263. PMID: 34477476.
   PubMed Web of Science ®Google Scholar